Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio filed an Investigational New Drug (IND) application...
Shanghai Fosun Pharma received a loan totaling 300...
Beijing Vigoo Biological, a vaccine-focused subsidiary of...
We profiled GeneHarbor Technologies, a company dedicated...
In 2011, China life science transformed itself from an...
The international biotech and pharma community will...
Jiangsu Hansoh Pharma is planning a $3 billion Hong Kong...
China Resources Pharmaceutical Group, China's second...
Veritas Genetics, a Boston-Hangzhou affordable genetics...
Deals and Financings
Shanghai Pharma may acquire part...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
